These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12011154)

  • 1. Naturally occurring mutations and functional polymorphisms in multidrug resistance 1 gene: correlation with microsatellite instability and lymphoid infiltration in colorectal cancers.
    Potocnik U; Ravnik-Glavac M; Golouh R; Glavac D
    J Med Genet; 2002 May; 39(5):340-6. PubMed ID: 12011154
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of P-glycoprotein (MDR1) polymorphisms and mutations in colorectal cancer.
    Potocnik U; Glavac MR; Golouh R; Glavac D
    Pflugers Arch; 2001; 442(6 Suppl 1):R182-3. PubMed ID: 11678332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-glycoprotein is not expressed in a majority of colorectal carcinomas and is not regulated by mutant p53 in vivo.
    De Angelis P; Stokke T; Smedshammer L; Lothe RA; Lehne G; Chen Y; Clausen OP
    Br J Cancer; 1995 Aug; 72(2):307-11. PubMed ID: 7640210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDR1 expression correlates with mutant p53 expression in colorectal cancer metastases.
    de Kant E; Heide I; Thiede C; Herrmann R; Rochlitz CF
    J Cancer Res Clin Oncol; 1996; 122(11):671-5. PubMed ID: 8898977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P-glycoprotein is positively correlated with p53 protein accumulation in human colorectal cancers.
    Oka M; Kounoura K; Narasaki F; Sakamoto A; Fukuda M; Matsuo I; Ikeda K; Tsurutani J; Ikuno N; Omagari K; Mizuta Y; Soda H; Gudas JM; Kohno S
    Jpn J Cancer Res; 1997 Aug; 88(8):738-42. PubMed ID: 9330605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional MDR1 polymorphisms (G2677T and C3435T) and TCF4 mutations in colorectal tumors with high microsatellite instability.
    Potocnik U; Ravnik-Glavac M; Glavac D
    Cell Mol Biol Lett; 2002; 7(1):92-5. PubMed ID: 11980438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of multidrug resistance related proteins Pgp, MRP1, and LRP/MVP occurs early in colorectal carcinogenesis.
    Meijer GA; Schroeijers AB; Flens MJ; Meuwissen SG; van der Valk P; Baak JP; Scheper RJ
    J Clin Pathol; 1999 Jun; 52(6):450-4. PubMed ID: 10562814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter.
    Yearsley M; Hampel H; Lehman A; Nakagawa H; de la Chapelle A; Frankel WL
    Hum Pathol; 2006 Jul; 37(7):831-8. PubMed ID: 16784982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status.
    Li WQ; Kawakami K; Ruszkiewicz A; Bennett G; Moore J; Iacopetta B
    Mol Cancer; 2006 Jan; 5():2. PubMed ID: 16403224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational analysis of promoters of mismatch repair genes hMSH2 and hMLH1 in hereditary nonpolyposis colorectal cancer and early onset colorectal cancer patients: identification of three novel germ-line mutations in promoter of the hMSH2 gene.
    Shin KH; Shin JH; Kim JH; Park JG
    Cancer Res; 2002 Jan; 62(1):38-42. PubMed ID: 11782355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo.
    Hoffmeyer S; Burk O; von Richter O; Arnold HP; Brockmöller J; Johne A; Cascorbi I; Gerloff T; Roots I; Eichelbaum M; Brinkmann U
    Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3473-8. PubMed ID: 10716719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation analysis using bisulfite treatment and PCR-single-strand conformation polymorphism in colorectal cancer showing microsatellite instability.
    Maekawa M; Sugano K; Kashiwabara H; Ushiama M; Fujita S; Yoshimori M; Kakizoe T
    Biochem Biophys Res Commun; 1999 Sep; 262(3):671-6. PubMed ID: 10471384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation in p14(ARF) is frequently observed in colorectal cancer with low-level microsatellite instability.
    Kominami K; Nagasaka T; Cullings HM; Hoshizima N; Sasamoto H; Young J; Leggett BA; Tanaka N; Matsubara N
    J Int Med Res; 2009; 37(4):1038-45. PubMed ID: 19761686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.
    Ogino S; Hazra A; Tranah GJ; Kirkner GJ; Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Meyerhardt JA; Hunter DJ; Fuchs CS
    Carcinogenesis; 2007 Sep; 28(9):1985-90. PubMed ID: 17621591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease?
    Ho GT; Moodie FM; Satsangi J
    Gut; 2003 May; 52(5):759-66. PubMed ID: 12692067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.
    Shin KH; Park YJ; Park JG
    Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers.
    Kuismanen SA; Holmberg MT; Salovaara R; de la Chapelle A; Peltomäki P
    Am J Pathol; 2000 May; 156(5):1773-9. PubMed ID: 10793088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsatellite instability in adenomas as a marker for hereditary nonpolyposis colorectal cancer.
    Loukola A; Salovaara R; Kristo P; Moisio AL; Kääriäinen H; Ahtola H; Eskelinen M; Härkönen N; Julkunen R; Kangas E; Ojala S; Tulikoura J; Valkamo E; Järvinen H; Mecklin JP; de la Chapelle A; Aaltonen LA
    Am J Pathol; 1999 Dec; 155(6):1849-53. PubMed ID: 10595914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDR and MRP gene families as cellular determinant factors for resistance to clinical anticancer agents.
    Deng L; Tatebe S; Lin-Lee YC; Ishikawa T; Kuo MT
    Cancer Treat Res; 2002; 112():49-66. PubMed ID: 12481711
    [No Abstract]   [Full Text] [Related]  

  • 20. Alterations of the Birt-Hogg-Dubé gene (BHD) in sporadic colorectal tumours.
    Kahnoski K; Khoo SK; Nassif NT; Chen J; Lobo GP; Segelov E; Teh BT
    J Med Genet; 2003 Jul; 40(7):511-5. PubMed ID: 12843323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.